Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 06, 2023

SELL
$1.88 - $36.45 $830 - $16,110
-442 Reduced 89.29%
53 $0
Q3 2022

Nov 02, 2022

SELL
$2.5 - $37.95 $427 - $6,489
-171 Reduced 25.68%
495 $1,000
Q2 2022

Aug 12, 2022

BUY
$1.75 - $11.34 $346 - $2,245
198 Added 42.31%
666 $1,000
Q1 2022

May 13, 2022

BUY
$10.21 - $20.29 $428 - $852
42 Added 9.86%
468 $4,000
Q4 2021

Feb 14, 2022

BUY
$16.76 - $22.99 $435 - $597
26 Added 6.5%
426 $8,000
Q2 2021

Aug 10, 2021

BUY
$18.28 - $33.05 $7,312 - $13,219
400 New
400 $7,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.54B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.